| Primary |
| Product Used For Unknown Indication |
73.3% |
| Cardiac Failure |
20.0% |
| Angina Pectoris |
6.7% |
|
|
| Secondary |
| Product Used For Unknown Indication |
30.5% |
| Prinzmetal Angina |
17.0% |
| Drug Use For Unknown Indication |
13.8% |
| Angina Pectoris |
5.2% |
| Hypertension |
4.9% |
| Cardiac Disorder |
3.9% |
| Rheumatoid Arthritis |
3.7% |
| Prophylaxis |
3.0% |
| Type 2 Diabetes Mellitus |
2.2% |
| Overdose |
2.0% |
| Osteoporosis |
1.7% |
| Suicide Attempt |
1.7% |
| Arteriosclerosis Coronary Artery |
1.5% |
| Cardiac Failure |
1.5% |
| Colon Cancer |
1.5% |
| Restless Legs Syndrome |
1.5% |
| Thrombosis |
1.5% |
| Thyroidectomy |
1.5% |
| Bronchial Carcinoma |
0.7% |
| Intentional Overdose |
0.7% |
|
| Abnormal Dreams |
12.9% |
| Hypotension |
9.7% |
| Neurological Symptom |
8.6% |
| Suicide Attempt |
7.5% |
| Troponin T Increased |
5.4% |
| Venous Thrombosis |
5.4% |
| Drug Tolerance |
4.3% |
| Liver Disorder |
4.3% |
| Overdose |
4.3% |
| Renal Failure Acute |
4.3% |
| Swollen Tongue |
4.3% |
| Tachycardia |
4.3% |
| Ventricular Fibrillation |
4.3% |
| Vertigo |
4.3% |
| Diabetes Mellitus Inadequate Control |
3.2% |
| Renal Failure |
3.2% |
| Tonsillar Ulcer |
3.2% |
| Altered State Of Consciousness |
2.2% |
| Cholestatic Liver Injury |
2.2% |
| Multiple Drug Overdose |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.5% |
| Drug Use For Unknown Indication |
20.8% |
| Angina Pectoris |
10.5% |
| Hypertension |
9.8% |
| Myocardial Ischaemia |
5.9% |
| Diabetes Mellitus |
3.4% |
| Cardiac Failure |
3.0% |
| Rheumatoid Arthritis |
2.7% |
| Prophylaxis |
2.6% |
| Acute Myocardial Infarction |
2.5% |
| Hypercholesterolaemia |
2.5% |
| Type 2 Diabetes Mellitus |
1.6% |
| Cardiac Disorder |
1.5% |
| Induction Of Anaesthesia |
1.4% |
| Urinary Tract Infection |
1.3% |
| Myocardial Infarction |
1.3% |
| Depression |
1.3% |
| Atrial Fibrillation |
1.3% |
| Coronary Artery Disease |
1.2% |
| Ill-defined Disorder |
1.2% |
|
| Rhabdomyolysis |
27.0% |
| Vomiting |
7.0% |
| Renal Failure Acute |
6.0% |
| Death |
5.3% |
| Myocardial Infarction |
5.3% |
| Pneumonia |
4.5% |
| International Normalised Ratio Increased |
4.1% |
| Angina Pectoris |
3.5% |
| Chest Pain |
3.5% |
| Liver Function Test Abnormal |
3.5% |
| Myalgia |
3.5% |
| Sepsis |
3.3% |
| Hypotension |
3.1% |
| Pancreatitis Acute |
3.1% |
| Pyrexia |
2.9% |
| Ventricular Dysfunction |
2.9% |
| Ventricular Fibrillation |
2.9% |
| Ventricular Tachycardia |
2.9% |
| Weight Decreased |
2.9% |
| Malaise |
2.7% |
|
| Interacting |
| Angina Pectoris |
29.4% |
| Essential Hypertension |
23.5% |
| Arthropathy |
11.8% |
| Coronary Artery Disease |
11.8% |
| Product Used For Unknown Indication |
11.8% |
| Atrial Fibrillation |
5.9% |
| Hypertension |
5.9% |
|
| Tibia Fracture |
50.0% |
| Vision Blurred |
25.0% |
| Fall |
12.5% |
| Renal Failure Acute |
12.5% |
|
